Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lingkai Xu"'
Autor:
Junlan Qiu, Yirong Xin, Jiazhen Yao, Lingkai Xu, Fang Meng, Lin Feng, Xiaochen Shu, Zhixiang Zhuang
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 854-864 (2023)
Background: A fundamental principle of pain management is to determine the distribution and causes of pain. However, relevant data among postoperative cancer patients based on a large amount of data remain sparse. Objective: We aimed to investigate t
Externí odkaz:
https://doaj.org/article/39563f124df64f09a54bbbc36e8a950e
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Objectives Synergism between the metabolic syndrome (MetSyn) components and cancer incidence still remains inconclusive. We aimed to investigate the unique or joint role of MetSyn components in cancer onset.Design We conducted a prospective nested ca
Externí odkaz:
https://doaj.org/article/49406f6c05a64987a9236126f13278f8
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 33:1245-1253
Autor:
Qingting Feng1, Lingkai Xu1, Lin Li1, Junlan Qiu2, Ziwei Huang3, Yiqing Jiang1, Tao Wen2, Shun Lu2, Fang Meng4, Xiaochen Shu1 xcshu@suda.edu.cn
Publikováno v:
Cancer Research & Treatment. Jul2021, Vol. 53 Issue 3, p714-723. 10p.
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-20 (2024)
Abstract Colorectal adenocarcinoma (COAD) is the most common subtype of colorectal cancer. Due to the imperfect prognosis of COAD, related prognostic factors and possible mechanisms need to be further investigated. During tumor development, mitochond
Externí odkaz:
https://doaj.org/article/7e2a642b6d704a5ca2c434aa87d07d82
Autor:
Qingting Feng, Xiaochen Shu, Fang Meng, Shun Lu, Yiqing Jiang, Lingkai Xu, Ziwei Huang, Junlan Qiu, Tao Wen, Lin Li
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The prevalence of multi-morbidities with colorectal cancer (CRC) is known to be increasing. Particularly prognosis of CRC patients co-diagnosed with metabolic syndrome (MetSyn) was largely unknown. We aimed to examine the death risk of CRC pa
Autor:
Junlan Qiu, Haifeng Zhang, Dongkui Xu, Lin Li, Lingkai Xu, Yiqing Jiang, Tao Wen, Shun Lu, Fang Meng, Lin Feng, Xiaochen Shu
Publikováno v:
Journal of oncology. 2022
Background. Although radical cystectomy (RC) is the clinical practice guideline-recommended treatment of muscle-invasive bladder cancer (MIBC), bladder-sparing trimodality therapy (TMT) has emerged as a valid treatment option. Findings comparing the
Publikováno v:
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology
Journal of Oncology
Muscle-invasive bladder urothelial carcinoma (MIBC) is characteristic of high mortality and high recurrence. Distinguishing the prognostic risk of MIBC at the molecular level of miRNA expression is rarely performed and thus of great significance for
Publikováno v:
Cancer Biol Ther
Muscle-invasive bladder urothelial carcinoma (MIBC) is a highly invasive cancer, which leads to prevalent recurrence and poor prognosis. Exploring the association of DNA methylation and the prognosis of MIBC will thus be of important value in clinica
Autor:
Lingkai Xu, Lin Li, Dongkui Xu, Junlan Qiu, Qingting Feng, Tao Wen, Shun Lu, Fang Meng, Xiaochen Shu
Publikováno v:
International journal of clinical oncology. 27(4)
Epidemiological evidence about hormone replacement therapy and colorectal carcinogenesis by demographic and clinical traits remains unclear. We aimed to assess this postulated association in a large multicentre study and further explore the modificat